Skip to content

The State of Nebulizer Therapy in Russian Federation

The State of Nebulizer Therapy in Russian Federation: a National Survey Among Medicine Physicians

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05617079
Acronym
SoNeT
Enrollment
370
Registered
2022-11-15
Start date
2023-07-01
Completion date
2025-07-31
Last updated
2025-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Disease, Respiratory Failure, Survey

Brief summary

It is known that the inhalation (nebulizer) use of drugs is of great importance in the intensive care of patients with acute and chronic respiratory failure of various origins. Searching PubMed data for the last 5 years (2017-2022) for the keywords nebulizer therapy revealed 533 publications, and mesh nebulizer therapy - only 25 sources. During the same period, the national database (E-Library) has 75 publications for the keywords nebulizer therapy, and 4 sources for mesh nebulizer therapy. It should be noted that almost all publications are devoted to the use of nebulizers for specific diseases and pathological syndromes. There are no works evaluating the adherence of specialists, systemic indications and actually used methods. The aim of trial is to study the current state of the use of nebulizer therapy in medical organizations and identify ways to improve its effectiveness This study is planned to be carried out using a questionnaire using a database based on the Internet electronic survey form.

Detailed description

We intend to involve at least 3 medical organizations in the subjects of the Russian Federation with a population of up to 1 million people; at least 5 medical organizations in the constituent entities of the Russian Federation with a population level of 1 to 3 million people, at least 7 organizations with a population level of more than 3 million people. In cities of the Russian Federation with a population of 1 million people or more - at least 5 medical organizations, and in the cities of Moscow and St. Petersburg - at least 10 medical organizations.

Interventions

OTHERSurvey

an electronic survey will be conducted

Sponsors

Russian Federation of Anesthesiologists and Reanimatologists
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Medical physicians

Exclusion criteria

* Lack of experience in conducting nebulizer therapy. Lack of technical capability for nebulizer therapy in a medical organization.

Design outcomes

Primary

MeasureTime frameDescription
Structure of indications, methods and frequency of use of nebulizer therapyup to 1 month after inclusionRegistration of the structure and indications for nebulizer therapy

Secondary

MeasureTime frameDescription
Drugs and frequency of their use during nebulizer therapyup to 6 month after inclusionRegistration of drugs used for nebulizer therapy
The frequency of use of nebulizer therapy for high-flow oxygen therapy, non-invasive ventilation and mechanical ventilationup to 6 month after inclusionFrequency of use of nebulizer therapy for various types of respiratory support

Countries

Russia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026